Tetrahydrobiopterin Slows the Progression of Atherosclerosis

We investigated whether oral tetrahydrobiopterin (BH4) treatment might slow the progression of atherosclerosis using hypercholesterolemic ApoE-knockout (KO) mice. We report that ingesting BH4 in drinking water is effective to inhibit atherogenesis in mice. Furthermore, we report that BH4 treatment i...

Full description

Bibliographic Details
Main Authors: Kunihiro Suzuki, Hattori Yoshiyuki, Jojima Teruo, Tomizawa Atsuko, Okayasu Toshie, Kase Hiroyuki, Kawagoe Yoshiaki, Banba Nobuyuki, Monden Tsuyoshi, Nakanishi Nobuo, Kasai Kikuo
Format: Article
Language:English
Published: De Gruyter 2007-02-01
Series:Pteridines
Subjects:
Online Access:https://doi.org/10.1515/pteridines.2007.18.1.115